The publishers of thousands of scientific journals have banned or restricted contributors’ use of an advanced AI-driven chatbot amid concerns that it could pepper academic literature with flawed and even fabricated research.
ChatGPT, a fluent but flaky chatbot developed by OpenAI in California, has impressed or distressed more than a million human users by rattling out poems, short stories, essays and even personal advice since its launch in November.
